Business Practice

Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.

Pharma sales teams are under pressure, but traditional training models aren’t keeping up. Can AI help?

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.

We ask a company about lessons learned from the GMP certification process.

A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in the pharmaceutical industry.

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.

Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.